Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Anastasia V Bereznikova"'
Autor:
Ivan A. Katrukha, Natalia S. Riabkova, Alexander E. Kogan, Alexandra V. Vylegzhanina, Kadriya Sh. Mukharyamova, Agnessa P. Bogomolova, Artur I. Zabolotskii, Ekaterina V. Koshkina, Anastasia V. Bereznikova, Alexey G. Katrukha
Publikováno v:
Clinica Chimica Acta. 542:117281
Autor:
Ivan A Katrukha, Alexey V. Kharitonov, Kogan Ae, Anastasia V. Bereznikova, Ekaterina V. Koshkina, Alexey G. Katrukha, Alexandra V Vylegzhanina, Vladimir L. Filatov, Natalia N. Tamm
Publikováno v:
Clinical Chemistry. 64:1104-1112
BACKGROUNDIn the blood of patients with acute myocardial infarction (AMI), cardiac troponin I (cTnI) presents as an intact molecule with a repertoire of proteolytic fragments. The degradation of cTnI might negatively influence its precise immunodetec
Autor:
Ekaterina V. Koshkina, Alexey G. Katrukha, Kogan Ae, Marina V. Serebryakova, Ivan A Katrukha, Anastasia V. Bereznikova, Alexandra V Vylegzhanina
Publikováno v:
Clinical Chemistry. 63:1094-1100
BACKGROUNDCardiac troponin T (cTnT) is an acknowledged biomarker of acute myocardial infarction (AMI) that is known to be prone to proteolytic degradation in serum. Such degradation is usually explained by the action of μ-calpain, although there cou
Autor:
A.N. Kara, Ekaterina V. Koshkina, Kogan Ae, Alexey G. Katrukha, Anastasia V. Bereznikova, Olga V Antipova, Alexandra V Vylegzhanina, Ivan A Katrukha
Publikováno v:
Clinical Chemistry. 63:343-350
BACKGROUND Autoantibodies to cardiac troponins (TnAAbs) could negatively affect cardiac troponin I (cTnI) measurements by TnAAbs-sensitive immunoassays. We investigated the epitope specificity of TnAAbs and its influence on cTnI immunodetection in pa
Autor:
Alexey G. Katrukha, Kogan Ae, Marina N. Bloshchitsyna, Alexandra V Vylegzhanina, Anastasia V. Bereznikova, Vladimir L. Filatov, Ivan A Katrukha, Ekaterina V. Koshkina, Agnessa P Bogomolova
Publikováno v:
Clinical chemistry. 65(7)
BACKGROUNDThe measurement of cardiac isoforms of troponin I (cTnI) and troponin T (cTnT) is widely used for the diagnosis of acute myocardial infarction (AMI). However, there are conflicting data regarding what forms of cTnI and cTnT are present in t
Autor:
Alexey G. Katrukha, Anastasia V. Bereznikova, Kogan Ae, Kadriya S. Mukharyamova, Vladimir L. Filatov, Marina N. Bloshchitsyna, Ekaterina V. Koshkina
Publikováno v:
Blood Coagulation & Fibrinolysis
Fibrin degradation results in the formation of fibrin degradation products (FDPs) of different molecular weights, which include D-dimer. Commercial D-dimer assays recognize multiple forms of FDP with different specificity. As a result, the absence of
Autor:
Alexey G Katrukha, Anastasia V Bereznikova, Ekaterina V Koshkina, Alexandra V Vylegzhanina, Alexander E Kogan, Ivan A Katrukha
Publikováno v:
Clinical Chemistry. 63:1769-1770
Autor:
Susann Eriksson, Johanna Ylikotila, Markus Vehniäinen, Kim Pettersson, Anastasia V. Bereznikova, Harri Takalo, Lasse Välimaa, Johanna L. Hellström
Publikováno v:
Clinical Biochemistry. 39:843-850
Objectives: To evaluate the performance of a new cTnI immunoassay utilizing site-specifically biotinylated recombinant Fab fragments on recently established spot wells. Design and methods: Two different cTnI-specific recombinant site-specifically bio
Autor:
Nikolai B. Gusev, A. Katrukha, Nikolai A. Gratsiansky, Igor R. Trifonov, Vladimir L. Filatov, Timo Lövgren, Olga V. Kolosova, Kim Pettersson, L.-M. Voipio-Pulkki, Tatiana V. Esakova, Kari Pulkki, Bulargina Tv, Anastasia V. Bereznikova
Publikováno v:
Clinical Chemistry. 44:2433-2440
We have analyzed by different immunological methods the proteolytic degradation of cardiac troponin I (cTnI) in human necrotic tissue and in serum. cTnI is susceptible to proteolysis, and its degradation leads to the appearance of a wide diversity of
Autor:
Nikolai B. Gusev, Evgeniy S. Severin, Tatiana V. Esakova, Anastasia V. Bereznikova, Olga V. Kolosova, Vladimir L. Filatov, A. Katrukha, Bulargina Tv
Publikováno v:
IUBMB Life. 45:1179-1187
Two groups of monoclonal antibodies (MAbs) specific to human cardiac troponin I (cTnI) were generated by immunization of mice by isolated cTnI (group I, 16 MAbs) or by the whole troponin complex (group II, 15 MAbs). Two sets of overlapping decapeptid